Ventyx Rises on Eli Lilly Talks, Mobileye, Strategy Rises
On this episode of Stock Movers:- Eli Lilly (LLY) is in advanced talks to acquire Ventyx Biosciences (VTYX) for more than $1 billion to expand its work in immunology, according to a report in the Wall Street Journal.Ventyx shares rose 60% at 4:38 p.m. in US postmarket trading to $16.13. At that price, the San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis is set to add $433.9 million to its market capitalization.- Self-driving car systems company Mobileye Global (MBLY) is acquiring Israeli startup Mentee Robotics in a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.